We describe a simple, rapid fluorometric assay for separate quantitative analysis of procainamide and Nacetyiprocainamide in mixtures. The effective linear range (fluorescence vs. concentration) in serum is 0.1 to 10.0 mg/liter, regardless of the ratio (by weight) of the two drugs from 1:10 to 10:1. Analytical recoveries by the extraction method used were 100.0 ± 3.0% and 98.0 ± 4.0%, respectively. For determination of either compound, the maximum coefficient of variation was 10%.
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AddItional Keyphrases: drug assay #{149} pKa #{149} quantum yield The therapeutic and toxic effects of procainamide (PA) are related to the concentration of the drug in the plasma of patients being treated (1) . N-Acetylprocainamide (NAPA) has recently been identified as a metabolite of PA that has antiarrhythmic activity in mice, dogs, and man (2, 3) . Because of this it is likely that NAPA contributes to the therapeutic efficacy and toxicity of PA.
Until now, NAPA in serum has been measured either by gas/liquid chromatography with use of capillary columns and flame-ionization detectors (3, 4) or by thin-layer chromatography with subsequent densitometry (5) . The technology required for either of these methods is not readily available to many clinical laboratories.
In contrast, spectrophotofluorometry is widely used in clinical laboratories and has been used to determine PA concentrations in serum and other biological fluids (6) . The present study describes a spectrophotofluorometric method for the estimation of NAPA in serum.
Methods
N-Acetylprocainamide was prepared as previously described (7) for analysis as previously described (7) , with the following modification. To minimize the rate of acid hydrolysis of NAPA to PA at room temperature (24 #{176}C), the compounds were extracted from the organic phase into 3.0 ml of 0.1 mol/liter HC1. and 310 nm (Figure 1-e) and the emission maximum at 358 nm (Figure 1-f) . Only one maximum, 279 nm, is found in the excitation of NAPA at pH 1 ( Figure   1-c) . The maximum emission intensity is found at 340 nm ( Figure  1-d) . Peak centers for excitation of NAPA at pH 11 were 250 and 295 nm ( Figure  1-g ) and for emission at 340 nm (Figure 1-h ).
Results
Quantum yield, , and log of PA and NAPA are presented in Table 1 . The log value shown is that of the lowest energy-corrected excitation maximum for a given material at a specified pH. Note that at pH 11, the 4 value for NAPA is a tenth that for PA, while at pH 1 the of NAPA is twice that of PA. The pKa of NAPA was experimentally determined to be 8.3 ± 0.1. 
N-Acetylprocainamide
Departure from linearity of a plot of fluorescence intensity vs. concentration for NAPA at pH 1 ( Figure   3 ) is similar to that observed for PA. (288 nm) = 2.82 )( 10 acm1concn1, and 4, = 0.01 (Table 1 ). The lower curve of this figure again shows the range of linearity in serum extending from 0.1 to 10.0 mg/liter (ig/ml). Table 1 . 

Discussion
Our results indicate that NAPA can be accurately The quantum yield of PA was reduced when the aromatic amine was fully titrated at pH 1, and the absorptivity of the longest excitation wavelength was only 4% of that found at pH 11 ( Table 1 ). Evidence that the excited-state singlet for PA is the same species regardless of pH can be seen in Figure 1- Figures 2 and 3) .
Even when the ratio of PA/NAPA is 10:1 or 1:10, the concentration of either compound can be accurately estimated if the critical absorbance is not ex- heparin, hydralazine, prednisone, and propranolol.
In conclusion, the technical aspects of this method are far simpler than those required for gas chromatography with capillary columns or for thin-layer chromatography and densitometry. The availability of instrumentation for the fluorometric determination of PA and NAPA should allow many more investigators to monitor the concentrations of both compounds in serum.
